Status:
COMPLETED
Recombinant Factor VII for Intractable Postpartum Haemorrhage
Lead Sponsor:
Aljazeera Hospital
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
18-45 years
Brief Summary
Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .
Detailed Description
Major postpartum haemorrhage is a dangerous complication that accounts for the highest maternal morbidity rate
Eligibility Criteria
Inclusion
- Women with severe resistant postpartum hemorage
Exclusion
- women without postpartum hemorage
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05298826
Start Date
June 1 2019
End Date
January 10 2020
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Doaaa Alaa
Cairo, Egypt